429A — Tekscend Photomask Balance Sheet
0.000.00%
- ¥404bn
- ¥365bn
- ¥130bn
Annual balance sheet for Tekscend Photomask, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Tanshin |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 48,369 | 63,286 | 27,715 | 52,539 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 23,069 | 27,838 | 31,085 | 36,214 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 75,332 | 95,777 | 64,082 | 97,369 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 63,315 | 72,836 | 87,919 | 109,074 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 157,963 | 189,906 | 167,752 | 230,725 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 25,288 | 33,015 | 33,314 | 34,582 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 47,359 | 52,197 | 51,371 | 56,218 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Unrealized Gain / Loss | ||||
| Other Equity | ||||
| Total Equity | 110,604 | 137,709 | 116,381 | 174,507 |
| Total Liabilities & Shareholders' Equity | 157,963 | 189,906 | 167,752 | 230,725 |
| Total Common Shares Outstanding |